Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

被引:0
|
作者
Roland Christian Schelker
Wolfgang Herr
Albrecht Reichle
Martin Vogelhuber
机构
[1] University Hospital Regensburg,Department of Internal Medicine III, Hematology & Oncology
来源
BMC Cancer | / 18卷
关键词
Diffuse large B-cell lymphoma; Rituximab; Trofosfamide; Elderly patients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
    Schelker, Roland Christian
    Herr, Wolfgang
    Reichle, Albrecht
    Vogelhuber, Martin
    BMC CANCER, 2018, 18
  • [2] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Hanno M. Witte
    Armin Riecke
    Thomas Mayer
    Tobias Bartscht
    Dirk Rades
    Hendrik Lehnert
    Hartmut Merz
    Sebastian Fetscher
    Harald Biersack
    Niklas Gebauer
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 129 - 136
  • [3] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
    Witte, Hanno M.
    Riecke, Armin
    Mayer, Thomas
    Bartscht, Tobias
    Rades, Dirk
    Lehnert, Hendrik
    Merz, Hartmut
    Fetscher, Sebastian
    Biersack, Harald
    Gebauer, Niklas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 129 - 136
  • [4] VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly
    Fina, Mariapaola
    Tani, Monica
    Stefoni, Vittorio
    Musuraca, Gerardo
    Marchi, Enrica
    Pellegrini, Cinzia
    Alinari, Lapo
    Derenzini, Enrico
    Bacci, Francesco
    Pileri, Stefano
    Baccarani, Michele
    Zinzani, Pier Luigi
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2167 - 2171
  • [5] RITUXIMAB MAINTENANCE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: SINGLE CENTER EXPERIENCE
    Popova-Simjanovska, M.
    Cevreska, L.
    Trajkova, S.
    Dukovski, D.
    Ivanovski, M.
    Stankovik, S.
    Panovska-Stavridis, I.
    HAEMATOLOGICA, 2013, 98 : 640 - 640
  • [6] Low-dose radiotherapy in diffuse large B-cell lymphoma
    Furlan, Carlo
    Canzonieri, Vincenzo
    Spina, Michele
    Michieli, Mariagrazia
    Ermacora, Anna
    Maestro, Roberta
    Piccinin, Sara
    Bomben, Riccardo
    Dal Bo, Michele
    Trovo, Marco
    Gattei, Valter
    Tirelli, Umberto
    Franchin, Giovanni
    Bulian, Pietro
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 472 - 479
  • [7] Bendamustine plus Rituximab as Treatment for Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Vacirca, Jeffrey
    Tabbara, Imad
    Acs, Peter
    Shumaker, Grace
    BLOOD, 2010, 116 (21) : 1157 - 1157
  • [8] Treatment for frail elderly patients with diffuse large B-cell lymphoma (DLBCL): A single center experience.
    Chaibi, Pascal
    Chebib, Amale
    Baudry, Elodie
    Cotto, Elise
    Piette, Francois
    Berigaud, Sylvie
    Siriwardana, Melany
    Mitha, Nathalie
    Koenig, Nelly
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] STOMACH DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
    Sung, M. -T.
    Chiou, L. -W.
    Huang, S. -N.
    Feng, A. -C.
    Wu, M. -C.
    Chen, P. -Y.
    Hsiao-Hsiang, C.
    Tan, T. -D.
    HAEMATOLOGICA, 2017, 102 : 697 - 697
  • [10] Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma
    Sarid, Nadav
    Joffe, Erel
    Gibstein, Lili
    Avivi, Irit
    Polliack, Aaron
    Perry, Chava
    Herishanu, Yair
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1633 - 1639